A new chapter for Cirq® for Cranial

13/08/2025

A new chapter for Cirq® for Cranial

Cirq® for LITT is now FDA(Food and Drug Administration)-cleared and available in the US —bringing a powerful new option to the table for treating patients with brain tumors or epilepsy.

This latest use case marks a key advancement for the Cirq® platform, enabling clinicians to transition seamlessly from diagnostic procedures like biopsy or SEEG (Stereoelectroencephalography) to minimally invasive laser therapy, all guided by robotic precision.

It’s a meaningful step toward broadening access to robotic-assisted neurosurgery and supporting better outcomes across the care pathway.